CLINICAL_TRIALS
trial_result
· 2017-10-20
Clinical Trial Update: 3 Month PHI PAD PoM Study [Phase 2]
Summary
GlaxoSmithKline completed a Phase 2 clinical trial in peripheral artery disease (PAD) and posted the results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Vascular Disease, Peripheral | Phase 2 | Status: COMPLETED | Results posted: 2017-10-20